Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib
- 1 May 2004
- journal article
- case report
- Published by Elsevier in Leukemia Research
- Vol. 28, 75-77
- https://doi.org/10.1016/j.leukres.2003.10.019
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003
- Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatmentBlood, 2003
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003
- Paroxysmal nocturnal haemoglobinuria: Nature's gene therapy?Molecular Pathology, 2002
- Cytogenetic and Molecular Monitoring of Residual Disease in Chronic Myeloid LeukaemiaActa Haematologica, 2002
- Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitroBlood, 2002
- Lymphoid Blast Crisis during Complete Cytogenetic Remission following Interferon-α and Hydroxyurea TherapyActa Haematologica, 1997
- Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five casesBritish Journal of Haematology, 1992